Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiseman

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Blood Cancer Journal|July 12, 2024
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemiaYu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, et al.
Stem Cell Reports|April 4, 2025
Competing dynamic gene regulatory networks involved in fibroblast reprogramming to hematopoietic progenitor cellsSamiyah Shafiq, Kiyofumi Hamashima, Laura A Guest, et al.
Cancer Cell|September 17, 2015
Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid LeukemiaTim D D Somerville, Daniel H Wiseman, Gary J Spencer, et al.
BMC Cancer|November 10, 2020
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancerMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
Leukemia|April 28, 2016
Frequent reconstitution of IDH2(R140Q) mutant clonal multilineage hematopoiesis following chemotherapy for acute myeloid leukemiaD H Wiseman, E L Williams, D P Wilks, et al.
Leukemia|April 9, 2021
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated originKiran Batta, Hasse M Bossenbroek, Naveen Pemmaraju, et al.
Cell Reports|September 22, 2021
Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemiaFabrizio Simeoni, Isabel Romero-Camarero, Francesco Camera, et al.
Leukemia|November 3, 2023
Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic targetYu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, et al.
Cell Reports. Medicine|February 1, 2025
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemiaKristian Gurashi, Yu-Hung Wang, Fabio M R Amaral, et al.
British Journal of Haematology|February 6, 2023
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemiaYu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Blood Cancer Journal|July 12, 2024
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemiaYu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, et al.
Stem Cell Reports|April 4, 2025
Competing dynamic gene regulatory networks involved in fibroblast reprogramming to hematopoietic progenitor cellsSamiyah Shafiq, Kiyofumi Hamashima, Laura A Guest, et al.
Cancer Cell|September 17, 2015
Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid LeukemiaTim D D Somerville, Daniel H Wiseman, Gary J Spencer, et al.
BMC Cancer|November 10, 2020
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancerMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
Leukemia|April 28, 2016
Frequent reconstitution of IDH2(R140Q) mutant clonal multilineage hematopoiesis following chemotherapy for acute myeloid leukemiaD H Wiseman, E L Williams, D P Wilks, et al.
Leukemia|April 9, 2021
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated originKiran Batta, Hasse M Bossenbroek, Naveen Pemmaraju, et al.
Cell Reports|September 22, 2021
Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemiaFabrizio Simeoni, Isabel Romero-Camarero, Francesco Camera, et al.
Leukemia|November 3, 2023
Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic targetYu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, et al.
Cell Reports. Medicine|February 1, 2025
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemiaKristian Gurashi, Yu-Hung Wang, Fabio M R Amaral, et al.
British Journal of Haematology|February 6, 2023
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemiaYu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, et al.
Pageof 16